Clinical Trials Directory

Trials / Completed

CompletedNCT01114594

Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
The Rogosin Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this pilot project is to assess the potential of urine micro-RNAs (miRNA) as biomarkers for characterizing patients with autosomal dominant polycystic kidney disease (ADPKD) compared with patients with other causes of chronic kidney disease.

Detailed description

Proteins and small molecules in urine (biomarkers) have been used to probe for kidney and systemic diseases for hundreds of years. Urine reportedly contains a type of molecule called microRNA (miRNAs) that regulate a large number of biological processes. Impaired function of miRNAs is now recognized in an increasing number of disease processes. In the search for new biomarkers, the regulatory function of miRNAs and the relative simplicity and precision of characterizing miRNAs, are potential advantages when compared to traditional biomarkers. The aim of this pilot project is to assess the potential of urine miRNAs as biomarkers for characterizing patients with autosomal dominant polycystic kidney disease (ADPKD), the most prevalent inherited cause of kidney failure. Individuals with other causes of chronic kidney disease (e.g., diabetes, glomerulonephritis), who are matched for key characteristics (e.g. age, sex, level of kidney function) will serve as the control population. A technique for isolation of miRNAs from urine samples will be tailored for the specific needs of this project. Biochemical and computational analysis of small RNAs from these samples will provide urine miRNA profiles and key variability statistics that will be use to design follow-up projects involving patients with kidney disease.

Conditions

Timeline

Start date
2010-04-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2010-05-03
Last updated
2018-11-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01114594. Inclusion in this directory is not an endorsement.